Profile Picture
  • All
  • Search
  • Images
  • Videos
  • Maps
  • News
  • Copilot
  • More
    • Shopping
    • Flights
    • Travel
  • Notebook
  • Top stories
  • Winter Games
  • Sports
  • U.S.
  • Local
  • World
  • Science
  • Technology
  • Entertainment
  • Business
  • More
    Politics
Order byBest matchMost fresh
  • Any time
    • Past hour
    • Past 24 hours
    • Past 7 days
    • Past 30 days

ap, Q4 and ACADIA

Digest more
Top News
Overview
Highlights
 · 1d
ACADIA Pharmaceuticals Q4 Earnings Call Highlights
ACADIA Pharmaceuticals (NASDAQ:ACAD) reported fourth-quarter and full-year 2025 results highlighted by double-digit revenue growth in its two commercial brands, NUPLAZID and DAYBUE, and issued 2026 gu...

Continue reading

 · 1d
Acadia: Q4 Earnings Snapshot
 · 2d
Range Resources: Q4 Earnings Snapshot
 · 5h
Dell Technologies: Fiscal Q4 Earnings Snapshot
Dell Technologies Inc. (DELL) on Thursday reported fiscal fourth-quarter earnings of $2.26 billion.

Continue reading

 · 1d
Pure Storage: Fiscal Q4 Earnings Snapshot
 · 1d
Essential Utilities: Q4 Earnings Snapshot
 · 5h
International Bancshares: Q4 Earnings Snapshot
The Laredo, Texas-based bank said it had earnings of $1.71 per share.

Continue reading

 · 1d
Synopsys: Fiscal Q1 Earnings Snapshot
Las Vegas Sun · 1d
Southwest Gas: Q4 Earnings Snapshot
3d

Why the 2026 GMC Acadia is a standout family SUV

The 2026 GMC Acadia midsize SUV impressed with its powerful engine, spacious interior and comfortable ride. See if this vehicle is worth its price.
5h

Acadia Healthcare Co Stock: A Deep Dive Into Analyst Perspectives (17 Ratings)

An in-depth analysis of recent analyst actions unveils how financial experts perceive Acadia Healthcare Co. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
20h

Acadia outlines 2026 revenue target up to $1.28B while advancing DAYBUE STIX and NUPLAZID growth

Management expects total revenues for 2026 between $1.22 billion and $1.28 billion, with NUPLAZID net sales projected at $760 million to $790 million and DAYBUE net sales expected between $460 million and $490 million. Adams stated these projections support confidence in achieving long-term targets and blockbuster status for NUPLAZID by 2028.
1d

Acadia Healthcare Q4 Earnings Beat Estimates on Rising Admissions

ACHC tops Q4 estimates as admissions and patient days rise, lifting revenues, but profit plunges 89% year over year.
1d

Debra Osteen back at Acadia helm with focus on 'missed details' and execution

Debra Osteen is back at the helm of Acadia Healthcare and she know exactly what the company needs to evaluate to rightsize the public company. Here's what she has planned and what
1don MSN

Acadia Healthcare outlines $3.37B–$3.45B 2026 revenue target as new CEO emphasizes operational discipline

Q4 2025 Management View Debra Osteen, CEO & Director, highlighted her return to the company and emphasized a renewed focus on stability, execution, and clear communication, stating, "My intention is to bring steady leadership,
1don MSN

Acadia Healthcare Posts Upbeat Q4 Earnings, Joins Circle Internet, Resideo Technologies And Other Big Stocks Moving Higher On Wednesday

U.S. stocks were higher, with the Nasdaq Composite gaining around 1% on Wednesday. Shares of Acadia Healthcare Company Inc ACHC rose sharply during Wednesday's session after the company reported better-than-expected quarterly financial results.
  • Privacy
  • Terms